Christopher Bowden - Net Worth and Insider Trading

Christopher Bowden Net Worth

The estimated net worth of Christopher Bowden is at least $914,043 dollars as of 2024-11-13. Christopher Bowden is the Chief Medical Officer of Agios Pharmaceuticals Inc and owns about 15,487 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $914,043. Details can be seen in Christopher Bowden's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Bowden has not made any transactions after 2021-06-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Christopher Bowden

To

Christopher Bowden Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Bowden owns 3 companies in total, including Viridian Therapeutics Inc (VRDN) , Agios Pharmaceuticals Inc (AGIO) , and Alaunos Therapeutics Inc (TCRT) .

Click here to see the complete history of Christopher Bowden’s form 4 insider trades.

Insider Ownership Summary of Christopher Bowden

Ticker Comapny Transaction Date Type of Owner
VRDN Viridian Therapeutics Inc 2017-08-10 director
AGIO Agios Pharmaceuticals Inc 2021-06-10 Chief Medical Officer
TCRT Alaunos Therapeutics Inc 2022-06-22 director

Christopher Bowden Latest Holdings Summary

Christopher Bowden currently owns a total of 1 stock. Christopher Bowden owns 15,487 shares of Agios Pharmaceuticals Inc (AGIO) as of June 10, 2021, with a value of $914,043.

Latest Holdings of Christopher Bowden

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AGIO Agios Pharmaceuticals Inc 2021-06-10 15,487 59.02 914,043

Holding Weightings of Christopher Bowden


Christopher Bowden Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Bowden has made a total of 7 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 28,002 shares on June 10, 2021, which brought Christopher Bowden around $2 Million.

Insider Trading History of Christopher Bowden

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Bowden Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Bowden Ownership Network

Ownership Network List of Christopher Bowden

No Data

Ownership Network Relation of Christopher Bowden

Insider Network Chart

Christopher Bowden Owned Company Details

What does Viridian Therapeutics Inc do?

Who are the key executives at Viridian Therapeutics Inc?

Christopher Bowden is the director of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & President and CEO Stephen F. Mahoney , Chief Operating Officer Thomas W. Beetham , and director & other: See Remarks Fairmount Healthcare Fund Ii Gp Llc .

Viridian Therapeutics Inc (VRDN) Insider Trades Summary

Over the past 18 months, Christopher Bowden made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 9,796 shares made by Lara Meisner , a net purchase of 1,600,000 shares made by Fairmount Healthcare Fund Ii Gp Llc , and a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc .

In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 1,626,400 shares, with a net purchase of 1,626,400 shares. During the past 18 months, 9,796 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,102,590 shares were bought by its insiders, resulting in a net purchase of 2,092,794 shares.

Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Viridian Therapeutics Inc Insider Transactions

No Available Data

Christopher Bowden Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Bowden. You might contact Christopher Bowden via mailing address: 38 Sidney Street, 2nd Floor, Cambridge Ma 02139.